2009
DOI: 10.1016/j.leukres.2009.03.028
|View full text |Cite
|
Sign up to set email alerts
|

Upregulation of stem cell genes in multidrug resistant K562 leukemia cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
14
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(17 citation statements)
references
References 48 publications
3
14
0
Order By: Relevance
“…Acaa2 was reported to be differentially expressed in CEM and drug-resistant leukemia cells [26]. Crot expression was found to be over-expressed in multidrug-resistant K562 leukemia cells [28]. In the current study, we found mRNA and protein levels of Acaa2, Aldh1l2, Acadvl, Echs1, and Hadha were significantly increased due to benzene exposure.…”
Section: Discussionsupporting
confidence: 56%
“…Acaa2 was reported to be differentially expressed in CEM and drug-resistant leukemia cells [26]. Crot expression was found to be over-expressed in multidrug-resistant K562 leukemia cells [28]. In the current study, we found mRNA and protein levels of Acaa2, Aldh1l2, Acadvl, Echs1, and Hadha were significantly increased due to benzene exposure.…”
Section: Discussionsupporting
confidence: 56%
“…In addition, ABCB5 gene silencing increases substantially the sensitivity of human melanoma cells to the anticancer chemotherapeutics 5-fluorouracil (5-FU) and camptothecin (112). A potential broader role for ABCB5 in anticancer chemotherapeutic resistance is suggested by the observation that across a panel of human cancer cell lines used by the National Cancer Institute for drug screening, ABCB5 gene expression levels correlate with chemoresistance to 45 of 119 anticancer agents (93), and the finding that human chronic myeloid leukemia cells resistant to the anticancer chemotherapeutic vincristine exhibit ABCB5 gene amplification and enhanced expression (113,114). These results warrant further in vivo examination to determine whether ABCB5-targeted sensitization to clinically relevant therapeutic agents represents a feasible and effective strategy to eradicate chemoresistant CSCs.…”
Section: Figurementioning
confidence: 99%
“…that development of drug resistance in a CML cell line results in ABCB5 gene amplification and mRNA overexpression and in the induction of stem cell genes raises the possibility that ABCB5 may serve similar chemoresistance functions in this malignancy, with potentially important implications should similar mechanisms be operative in drug-resistant clinical leukemias. (86,87) Since ABCB5 + CSC frequency also correlated significantly with clinical melanoma progression,(26) the ABCB5 marker identified a novel, direct link between CSC, cancer therapeutic resistance, and clinical neoplastic progression in a human malignancy.…”
Section: Cancer Stem Cell-mediated Resistance To Conventional Tumor Tmentioning
confidence: 99%